Inovio Pharmaceuticals Inc - INO - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: June 16, 2013

Inovio Pharmaceuticals Inc - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
INO	American	8731	http://www.inovio.com/	0.682 -0.017
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Inovio Pharmaceuticals Inc Inovio Pharmaceuticals: 2 100% Results In 2 Months - Jun 14th, 2013 1:07 pm Ford’s Ambitious Carbon Agenda, Inovio Surges on Flu Treatment, and 3 More Hot Stocks - Jun 14th, 2013 9:01 am Inovio's Universal H7N9 DNA Vaccine Generates First Protective Antibody Responses Against Virulent H7N9 Virus in 100% of Vaccinated Animals - Jun 14th, 2013 2:00 am Sorting Out Inovio Claims - Jun 12th, 2013 12:13 am Corporate Profile Inovio Pharmaceuticals, Inc. - Jun 10th, 2013 6:00 pm INOVIO PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Amendments to A - May 21st, 2013 7:07 am INOVIO PHARMACEUTICALS, INC. Financials - May 17th, 2013 11:04 am Why You Should Be Investing In DNA Vaccination Technology And Inovio Pharmaceuticals - May 16th, 2013 9:38 am A Comprehensive Overview Of Active Electroporation Cancer Trials - May 14th, 2013 8:57 am Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study - May 14th, 2013 7:16 am Inovio Pharmaceuticals: Why Best Therapeutic Vaccine Award In 2013? - May 14th, 2013 5:15 am Inovio Pharmaceuticals Reports 2013 First Quarter Financial Results - May 10th, 2013 2:41 pm INOVIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report - May 10th, 2013 7:27 am Narrower than Expected Loss at Infinity - May 9th, 2013 6:35 am Corporate Profile Inovio Pharmaceuticals, Inc. - May 8th, 2013 6:00 pm Speculative Bio Stocks For Investors - May 8th, 2013 8:29 am Imminent Catalysts For Small Pharmaceuticals - May 7th, 2013 10:47 am Different Threats, Different Solutions, Many Ways To Make Money - May 2nd, 2013 10:40 am A Tale Of Three Pharmaceuticals: Getting Exciting In 2013 - Apr 29th, 2013 10:53 am RedChip Emerging Growth Showcase Takes Place May 1 - Apr 23rd, 2013 9:15 am View All Current Headlines >>